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Purpose: To characterize an N-ethyl-N-nitrosourea-induced dominant mouse mutant, M-1156, that exhibits progressive
retinal degeneration and to investigate the pathogenesis of the retinal phenotype in the mutant.
Methods:  A  positional  candidate  gene  approach  was  used  to  identify  the  causative  gene  in  the  M-1156  mutant.
Funduscopic examination, light microscopy, transmission electron microscopy, and electroretinography were performed
to analyze the M-1156 phenotype. Real-time quantitative PCR, immunohistochemistry, and western blotting were also
performed.
Results: Linkage analysis enabled the mutant gene to be mapped to a region of chromosome 19 containing Rom1, which
encodes rod outer segment membrane protein 1. Sequence analysis demonstrated that the mutation consisted of a single
base T→C substitution at position 1,195 in Rom1 (M96760, National Center for Biotechnology Information [NCBI]) and
that the mutant allele was expressed. A putative missense mutation designated Rom1Rgsc1156 that was identified in the
M-1156 mutant mouse causes a Trp to Arg substitution at position 182 in the translated protein. Rom1Rgsc1156 heterozygotes
were found to have a mottled retina and narrowed arteries in the fundus oculi. Photomicrographs of the retina revealed
significant differences among the genotypes in the thickness of the outer nuclear layer and in the length of the outer
segments of the photoreceptors. The alterations were more marked in the homozygotes than in the heterozygotes. Electron
micrographs showed that the diameters of the discs varied in the heterozygotes and that the discs were more compactly
stacked than in the wild type. There were significant differences among the genotypes in the amplitude of the a-wave in
single-flash electroretinograms, but there were no significant differences among the photopic electroretinograms. Real-
time quantitative PCR showed that there were no significant differences among the genotypes in Rom1 or peripherin/rds
(Prph2) mRNA levels relative to the rhodopsin (Rho) mRNA level. Rom1 and Prph2 immunoreactivity were decreased
in the retinas of the Rom1Rgsc1156 mutants. Semiquantitative western blot analysis of retinas from 3-week-old Rom1Rgsc1156
mutants demonstrated significant decreases in Rom1, Prph2, and Rho protein levels in all of the genotypes.
Conclusions: The Trp182Arg substitution in Rom1Rgsc1156 mutants causes retinal degeneration. The results suggested that
Trp182Arg mutant Rom1 causes a decrease in the levels of wild-type Prph2 and Rom1, which in turn cause a reduction
in the level of Prph2 containing tetramers in the disc rim region and ultimately result in unstable, disorganized outer
segments and photoreceptor degeneration.
Retinitis pigmentosa (RP) is a genetically heterogeneous
disorder that may be inherited as an autosomal dominant,
autosomal recessive, or X-linked trait [1] and it affects about
one in 5,000 individuals worldwide. RP patients progressively
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lose vision because both rods and cones throughout the retina
gradually die. Mutations of genes that are mainly expressed
in  photoreceptors  and  retinal  pigment  epithelium  are
associated with RP, and phenotypic severity depends on the
causative gene.
Rod  outer  segment  membrane  protein  1  (Rom1)  and
peripherin/rds  (Prph2),  which  are  structurally  similar,  are
localized along the rim region of photoreceptor discs. They
are 35% identical at the amino acid level and contain four
putative  membrane-spanning  domains,  a  large  intradiscal
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378loop  that  connects  the  third  and  fourth  transmembrane
domains, and a long C-terminal segment [2-4]. rds mice that
are  homozygous  for  a  null  mutation  in  peripherin/rds
(Prph2)  fail  to  develop  outer  segments,  and  highly
disorganized  structures  form  in  heterozygous  rds  mice;
homozygous Rom1 knockout mice develop outer segments
with only mild defects [5-10]. Thus, Prph2 is likely to play a
more  important  role  than  Rom1  in  the  formation  and
stabilization of photoreceptor outer segments.
Mutations  in  peripherin/retinal  degeneration,  slow
(PRPH2)  cause  hereditary  human  retinal  degenerative
diseases that are characterized by autosomal dominant RP and
macular  dystrophy  [11-14],  and  most  of  the  pathological
changes are localized within the large intradiscal loop. By
contrast,  there  has  been  no  clear  evidence  thus  far  that
mutations  in  retinal  outer  segment  membrane  protein  1
(ROM1) alone cause retinal degeneration [15], although it is
well known that only persons who are double heterozygous for
ROM1 and PRPH2 develop RP in a digenic inheritance pattern
[16].
N-ethyl-N-nitrosourea  (ENU)  is  a  powerful  chemical
mutagen that induces random point mutations in genomic
DNA  with  high  frequency  [17-20].  Phenotype-based
screening enables comprehensive collection of mutations in
genes involved in specific biologic pathways. Because human
genetic diseases are often caused by point mutations rather
than gross alterations of the genome, ENU mutagenesis is
suitable for production of mutants that can serve as models of
human disease [21-24].
Our  ENU  mutagenesis  project  has  yielded  several
dominantly inherited mouse mutations that are manifested by
retinal and/or optic disc abnormalities, and one of the mutant
mice  manifested  progressive  retinal  degeneration.  A
positional candidate gene approach enabled a point mutation
in Rom1 to be identified as the cause of this phenotype. The
results  of  this  study  provide  evidence  that  a  monogenic
dominant mutation in Rom1 induces retinal degeneration. We
analyzed the phenotype of the mutants in detail, and in this
article we discuss potential implications for the pathogenesis
of retinal degeneration.
METHODS
Generation and phenotype-based screening of mice for N-
ethyl-N-nitrosourea-induced  mutants:  We  performed  the
animal studies under the guidelines issued by the RIKEN
BioResource  Center  (Tsukuba,  Japan)  in  the  “Outline  for
conducting animal experiments” (issued August 1999, revised
October 2001). We obtained stock mice from CLEA Japan,
Inc.  (Tokyo,  Japan).  The  method  used  for  mouse  ENU
mutagenesis is available at RIKEN BioResource Center ENU
Mutants website and has been described previously [20-24].
At  8–10  weeks  of  age,  C57BL/6J  male  mice  were
intraperitoneally  injected  with  85  mg/kg  or  100  mg/kg
bodyweight ENU (Sigma, Tokyo, Japan) twice at weekly
intervals. The injected male mice were mated with DBA/2J
female  mice  after  a  sterile  period  (approximately  10–11
weeks). Phenotypic screenings were routinely performed on
the first generation (G1) progeny. Funduscopy was performed
at  45  weeks  of  age.  Phenodeviant  individuals  (mutant
candidates) were assigned M numbers.
Funduscopic  examination:  Pupils  were  dilated  with  0.5%
tropicamide and 0.5% phenylephrine (Santen Pharmaceutical
Co., Ltd., Osaka, Japan) diluted 5–7.5 fold with physiologic
saline. The fundi were examined by indirect ophthalmoscopy,
and  photographs  were  taken  by  using  a  GENESIS  hand
funduscope camera (Kowa Co., Ltd., Nagoya, Japan) with a
Volk 90D condensing lens (Volk Optical, Mentor, OH), as
described  [25-27].  In  short,  the  camera  was  fitted  to  a
dissection microscope base for stability and a foot pedal was
used to operate the shutter. Photographs were taken using
conscious mice. One hand was used to hold the mouse while
two fingers of the other hand were used to retract the eyelids.
We used the condensing lens mounted between the camera
and eye. The mouse was held on its side on the microscope
platform beneath the lens. Focusing was achieved by moving
the mouse.
Inheritance testing and gene mapping: To test for phenotype
transmission and to genetically map the causative gene, we
backcrossed M-1156 with DBA/2J animals and recovered 125
backcross (N2) progeny. Because it was difficult to determine
whether 16 of the 125 mice had abnormal fundi at 25 weeks
of  age,  they  were  not  used  in  the  chromosome  mapping
analysis. Genomic DNA was prepared from the tail tips of the
109  remaining  backcross  progeny  by  using  the  NA-2000
automatic nucleic acid isolation system (KURABO, Osaka,
Japan). We used the db-SNP website for single nucleotide
polymorphisms (SNPs) and microsatellite markers listed on
the Mouse Genome Informatics (MGI website) for simple
sequence  length  polymorphisms.  After  examining  118
polymorphic markers spaced evenly throughout the genome
by the TaqMan MGB assay (Applied Biosystems, Tokyo,
Japan)  and  ABI  7700  and  ABI  7900  sequence  detection
systems, five markers (D19Mit109, D19Mit42, D19Mit69,
D19Mit110, and rs3023477) on chromosome 19 were chosen
for fine mapping of the causative gene.
Search of the M-1156 genome for the causative mutation: We
used  Positional  MEDLINE  (PosMed),  a  semantic  Web
system, to provide a list of ranked candidate genes within the
region [28,29] to search for the causative mutation in the
mapped chromosomal region. We designed primer pairs based
on  the  genomic  sequence  of  Rom1  (NC_000085)  and
sequenced the region from –110 bases upstream to 1,889 bases
downstream of the Rom1 gene to search for mutations of the
M-1156 genome.
Genotyping  of  the  M-1156  Rom1  allele:  The  Rom1Rgsc1156
allele was genotyped by allele-specific primer-PCR methods.
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379The wild-type-specific primer (5′-AAG TAA CGG TTG CTG
ACC GA-3′) or the Rgsc1156-specific primer (5′-AAG TAA
CGG TTG CTG ACC GG-3′) was paired with a common
opposite-strand primer (5′-GCT TTG CCA GTA AGT CTC
AA-3′).
Electroretinogram: Single-flash electroretinograms (ERGs)
of both eyes of Rom1Rgsc1156 mutant mice were obtained at 7,
35, and 50 weeks of age. Mice were dark adapted overnight
and then prepared for recording under dim red light. The mice
were  anesthetized  with  an  intraperitoneal  injection  of
physiologic saline containing ketamine (80 mg/kg; Daiichi
Sankyo Propharma Co., Ltd., Tokyo, Japan) and xylazine
(16 mg/kg; Bayer Medical Ltd., Tokyo, Japan). Their pupils
were dilated with 0.5% tropicamide and 0.5% phenylephrine,
and their corneas were anesthetized with 0.4% oxybuprocaine
hydrochloride (Santen Pharmaceutical Co., Ltd.) to prevent
blinking. Mice were placed prone on a temperature-regulated
heating pad throughout the recording session. After coating
the  cornea  with  drops  of  1.5%  hydroxyethylcellulose  gel
(Senju Pharmaceutical Co., Ltd., Osaka, Japan), a 2.8-mm
diameter  customized  white-light-emitting  diode  (LED)
electrode  (Mayo  Corporation,  Ltd.,  Inazawa,  Japan)  was
placed on the surface of the cornea with a micromanipulator
and used as a recording electrode. A stainless-steel needle was
attached  subcutaneously  to  the  nasal  bone  as  a  reference
electrode,  and  another  stainless-steel  needle  was  inserted
subcutaneously near the tail as a ground electrode. The flash
stimulus was controlled by a white LED luminescent device
(LS-W:  Mayo  Corporation,  Ltd.).  Electrical  signals  were
amplified  with  a  Dual  Bio  Amp  (Model  ML135;
ADInstruments Pty. Ltd., New South Wales, Australia) at a
gain of 4,000 and bandpass filtered between 0.3 and 500 Hz
(–3 dB points). Signals were digitized at a rate of 10 kHz with
a  data  acquisition  device  (PowerLab2/25,  Model  ML825;
ADInstruments  Pty.  Ltd.).  Stimulus  presentation  and  data
acquisition  were  programmed  and  performed  with  data
recording and analysis software (Scope v3.7; ADInstruments
Pty. Ltd.). Flash stimuli were 5 ms in duration and had an
intensity of 1,000 cd/m2 measured at the eye. A total of five
responses obtained at 1–min intervals were averaged for each
eye. The amplitude of the a-wave was measured from the
prestimulus baseline to the a-wave trough. The amplitude of
the b-wave was measured from the a-wave trough to the peak
of the b-wave or, if the a-wave was not measurable, from the
prestimulus baseline.
Photopic  ERGs  were  obtained  from  single  eyes  of
Rom1Rgsc1156 mutant mice at 7 weeks of age. Light-adapted
responses were recorded with white flashes (5 ms duration and
1,000 cd/m2 intensity) on the rod-saturating background (25.1
cd/ m2) after 10 min of exposure to the background light to
allow  complete  light  adaptation.  A  total  of  16  responses
obtained at 1-s intervals were computer averaged for each eye.
Light microscopy: Anesthetized mice with an intraperitoneal
injection  of  physiologic  saline  containing  pentobarbital
sodium (90 mg/kg; Kyoritsu Seiyaku Co., Ltd., Tokyo, Japan)
were  intracardially  perfused  with  4%  paraformaldehyde
(Nacalai Tesque, Inc., Kyoto, Japan) /2.5% glutaraldehyde
(Wako Pure Chemical Industries, Ltd., Osaka, Japan) in 0.1
M phosphate buffer (PB). Eyes were enucleated and fixed in
fresh fixing buffer for 1 day at room temperature and then
dehydrated by immersion in a series of increasing ethanol
concentrations. After three changes of xylene, the eyes were
embedded in paraffin wax. A mid-horizontal series of sections
(3-µm thick) through the optic nerve head of each eye was
prepared. The sections were stained with hematoxylin and
eosin (Muto Pure Chemicals Co., Ltd., Tokyo, Japan) by the
standard  protocol  and  viewed  with  an  AX80  microscope
(Olympus  Inc.  Tokyo,  Japan).  The  thickness  of  the  outer
nuclear layer and inner nuclear layer and the length of the
outer segment of the photoreceptors were measured by light
microscopy at the point where the ratio of the distance from
the optic disc to the point to the distance from the optic disc
to peripheral end of the retina was 0.2, as described elsewhere
[30].
Transmission electron microscopy: Anesthetized mice were
intracardially  perfused  with  2%  paraformaldehyde/2.5%
glutaraldehyde in 0.1 M PB. Eyes were enucleated and fixed
in fresh fixing buffer for 1 day. The anterior segments of the
eyes  were  removed,  and  the  eyecups  were  postfixed  for
another  day.  After  rinsing  the  eyecups,  eyecups  were
immersed for 1 day in 0.1 M PB at 4 °C. The eyecups were
osmicated for 2 h in 1% aqueous solution of osmium tetroxide
(TAAB Laboratories Equipment Ltd., Aldermaston, Berks,
England)  at  4  °C  and  then  dehydrated  through  ascending
ethanol concentrations (50%, 70%, 80%, 90%, and 100% for
30 min each). After passing the specimens through propylene
oxide (Wako Pure Chemical Industries, Ltd., Osaka, Japan)
twice for 1 h each time, the specimens were embedded in pure
Epon (TAAB Laboratories Equipment Ltd.) for 2 days at
60 °C. Ultrathin sections were cut with a microtome (U-5;
LBK Instruments Ltd., Bromma, Sweden), and the sections
(80–100 nm) were stained with saturated uranyl acetate and
Reynolds lead citrate (Wako Pure Chemical Industries, Ltd.).
The sections were examined with an electron microscope at
80 kV (JEM-100S; JEOL, Tokyo, Japan).
Preparation  of  anti-Rom1  and  anti-Prph2  monoclonal
antibodies:  A  synthetic  13-mer  for  Rom1
(LAHYKDTEVPGRC)  and  a  20-mer  for  Prph2
(CKSNQVEAEGADAGPAPEAG), corresponding to amino
acids 141–153 in mouse Rom1 and 328–346 in mouse Prph2,
respectively, were purchased from Invitrogen (Carlsbad, CA).
The  peptides  were  conjugated  with  keyhole  limpet
hemocyanin (KLH; Pierce, Rockford, IL) and injected into
BALB/ cAJcl mice four times at 2-week intervals. Three days
after the final booster shot, lymph node cells were fused with
myeloma line P3U1 cells. The cells were cultured in GIT
medium (Nihon Pharmaceutical Co. Ltd., Tokyo, Japan) for
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38014 days, and the culture supernatants were screened first by
Enzyme-Linked  ImmunoSorbent  Assay  (ELISA)  against
immunized  peptides.  Then,  the  positive  samples  were
subjected to western blot analysis for extracts from Cos-7 cells
overexpressing either Rom1 or Prph2. Hybridoma cells from
the  positive  wells  were  cloned  by  the  standard  limiting
dilution technique [31]. Anti-Rom1 (clones 1–38) and anti-
Prph2 (clones 7–27) were used in this study.
Immunohistochemistry:  Anesthetized  mice  were
intracardially perfused with 4% paraformaldehyde in ice-cold
0.1 M PB, and the eyes were enucleated and fixed for 1 day
at 4 °C. The anterior segments were removed, and the eyecups
were immersed in a graded series of sucrose solutions (10%
W/V, 20%, and 30%) in PBS (8.10 mM NaHPO4, 1.47 mM
KHPO4, 137 mM sodium chloride, 2.68 mM KCl, pH 7.4) at
4 °C for 1 day per step; the eyecups were then embedded in
Figure 1. Appearance of the fundus of an M-1156 mouse and a control mouse. At 45 weeks of age, the retinas of M-1156 mice were mottled
and their arteries (indicated by arrows) were narrower than in the retinas of control mice which were F1 mice from crossing DBA/2J mice
and C57BL/6J mice; DBF1. M-1156 mouse has same genetic background with DBF1.
Figure  2.  Haplotype  analysis  and
genetic map of M-1156. A: Haplotype
analysis of 109 backcross (N2) progeny
from crossing M-1156 and DBA/2J was
shown. Genetic markers are listed on the
left  side  (rs3023477  is  a  single
nucleotide  polymorphism  [dbSNP]).
Each column represents a chromosomal
haplotype  identified  in  the  progeny.
C57BL/6J alleles are indicated by black
boxes, and DBA/2J alleles are indicated
by  white  boxes.  M-1156  denotes  the
mutant locus. B: Genetic map around
the causative gene was shown. The map
distances (in cM) are shown on the left
side  of  the  map.  The  mutant  locus
M-1156 was mapped close to D19Mit42
on mouse chromosome 19.
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381Tissue-Tek OCT Compound (Sakura Finetek, Tokyo, Japan)
and frozen in acetone at dry-ice temperature. A mid-horizontal
series of 10-µm-thick sections through the optic nerve head
of each eye was prepared, and the sections were allowed to
dry  in  air.  After  incubation  in  0.3%  hydrogen  peroxide
(H2O2) for 10 min and rinsing in PBS for 5 min, the sections
were blocked for 30 min with 1% bovine serum albumin
(BSA) in PBS and washed three times with PBS for 5 min
each time. The sections were then incubated for 16 h at 4 °C
with Rom1 or Prph2 monoclonal antibody diluted 1:400 in 1%
BSA/PBS. After washing three times in PBS for 5 min each
time, the sections were treated with the Envision kit (DAKO,
Tokyo, Japan) as follows: The sections were incubated for 16
h at 4 °C with a secondary goat-antimouse Immunoglobulin
G (IgG; DAKO) conjugated to horseradish peroxidase (HRP,
DAKO). After washing three times in PBS for 5 min each
time,  the  sections  were  developed  with  0.03%  3,3-
diaminobenzidine  tetrahydrochloride  (DAKO)  solution
containing 0.005% H2O2. After visualization, sections were
washed  in  water  for  5  min  and  counterstained  with
hemotoxylin for 10 s. After washing in water for 10 min, the
sections were dehydrated with ethanol and penetrated with
xylene.  The  sections  were  examined  with  an  AX80
microscope (Olympus Inc.). Peptide absorption tests of both
monoclonal antibodies were performed.
Real-time quantitative PCR: Retinal expression of Rom1 and
Prph2 mRNA was measured by real-time quantitative PCR
(qPCR). The eyes of 8-week-old mice were enucleated, and
the  retinas  were  dissected  from  the  eyecups  in  ice-cold
RNAlater (Product number No.7020; Applied Biosystems).
Total  RNA  was  extracted  from  the  retinas  with  TRIzol
(Invitrogen). Real-time qPCR was performed by using the
SYBR® Reverse-Transcriptase (RT)–PCR kit (product code
RR045A;  TaKaRa,  Shiga,  Japan),  according  to  the
manufacturer’s protocol. Briefly, single-stranded cDNA was
synthesized  from  each  RNA  sample  with  Rnase  H  free
MMLV  RTase  (Takara)  and  random  6-mers  on  a  PCR
Thermal  Cycler  GP  (TaKaRa).  The  cDNA  obtained  was
amplified  on  a  Smart  Cycler  II  rapid  DNA  amplification
system  (Cepheid,  TaKaRa)  with  a  SYBR®  RT–PCR  kit,
which contains SYBR Premix Ex Taq, SYBR Green I, and
deoxyribonucleotide  triphosphates  (dNTPs).  The  PCR
reaction was run under the following conditions: denaturation
at 95 °C for 10 s, followed by 45 cycles of 95 °C for 5 s, and
60 °C for 20 s. The levels of glyceraldehyde-3-phosphate
dehydrogenase (Gapdh) mRNA and rhodopsin (Rho) mRNA
were  used  as  endogenous  controls  for  each  sample.  The
mRNA levels in each sample were determined by using a
calibration curve. Separate calibration (standard) curves for
each gene were constructed by using serial dilutions of mRNA
from a mouse retina of the same strain that had not been
exposed to ENU. Primer sets for amplifying each gene were
chosen from exons separated by an intron. The primer sets
used in this analysis were: for Rom1, forward primer 5′-GCC
ATG AAG TGC TGC TGG AA-3′, reverse primer 5′-GTC
TGC AAA TAC CGC AAA CCA AG-3′; for Prph2, forward
primer 5′-ACC ATC GAC ATG CTC CAG ATT G-3′, reverse
primer  5′-CCC  ATC  CAC  GTT  GCT  CTT  GA-3′;  for
Gapdh, forward primer 5′-AAA TGG TGA AGG TCG GTG
TG-3′, reverse primer 5′-TGA AGG GGT CGT TGA TGG-3′;
and for Rho, forward primer 5′-TTG GGC CCA CAG GCT
GTA A-3′, reverse primer 5′-CCG AAG CGG AAG TTG
CTC A-3′.
Western blotting: Retinas were dissected from eyes collected
from 3-week-old mice and homogenized by sonication in ice-
cold  buffer  (20  mM  Tris  [pH.  7.6],  137  mM  NaCl,  10%
glycerol, 1% NP-40) containing protease inhibitor (1 mM
phenylmethylsulfonyl  fluoride;  Sigma-Aldrich,  Tokyo,
Japan, 10 μg/ml aprotinin ; Sigma-Aldrich, Tokyo, Japan,
1 μg/ml leupeptin ; Peptide Institute, Inc., Osaka, Japan). After
Figure 3. Sequence analysis of Rom1. The position of the point mutation is indicated by red arrowheads on sequence chromatograms from
the Control DBF1 mouse (top) and the M-1156 mouse (bottom). A T→C single base substitution at position 1,195 of Rom1 (M96760, National
Center for Biotechnology Information [NCBI]) was identified in the M-1156 mouse line.
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382centrifugation at 10,000× g for 15 min at 4 °C, the supernatant
was collected and protein concentrations were determined
with a bicinchoninic acid (BCA) protein assay kit (Product
number 23225; Thermo Fisher Scientific, Rockford, IL), with
BSA used as a standard. For western blotting of Rom1 and
Prph2, 10 µg of the retinal protein was mixed with the same
volume of 2× loading buffer (140 mM Tris [pH. 6.8], 140 mM
NaCl,  60%  glycerol,  4%  sodium  dodecyl  sulfate,  0.02%
bromophenol blue, 5.0% β-mercaptoethanol) and boiled for
10 min. The prepared protein samples were electrophoresed
by 12.5% sodium dodecyl sulfate–PAGE and transferred to
Immobilon  transfer  membranes  (polyvinylidene  difluoride
membrane, Millipore, Tokyo, Japan). The membranes were
blocked  with  3%  BSA  in  Tris-Buffered  Saline  Tween-20
(TBST;  20  mM  Tris  [pH.  7.6],  137  mM  NaCl,  0.1%
Tween-20) for 60 min and incubated for 60 min with mouse
Rom1 antibody diluted 1:50 or mouse Prph2 antibody diluted
1:30 in TBST. After washing with TBST three times for 10
min each, the membranes were incubated with goat antimouse
IgG  conjugated  to  HRP  (Product  No.  62–6320;  ZYMED
Laboratories, San Francisco, CA). After washing with TBST
three times for 10 min each, the membranes were immersed
in  Immobilon  Western  Chemiluminescent  HRP  Substrate
(Millipore), and then immediately exposed to an LAS-3000
imaging system (FUJIFILM, Tokyo, Japan) to visualize the
immunoreactive  signals.  Signal  intensities  were
densitometrically quantitated with the ImageJ 1.41 software
program (National Institutes of Health, Bethesda, MD). For
western blotting of Rho, 0.1µg of the retinal protein was mixed
with the same volume of 2× loading buffer. Samples were
electrophoresed  and  transferred  to  a  membrane  without
boiling. Mouse antibovine rhodopsin monoclonal antibody
(Product No. MAB5356, clone name Rho 1D4; Chemicon,
Temecula,  CA)  was  diluted  1:  4,000  in  high-salt  TBST
Figure 4. Photomicrographs of retinas
from 7- (A, B, C) and 35- (D, E, F)
week-old Rom1+/+, Rom1Rgsc1156/+, and
Rom1Rgsc1156/Rgsc1156  mice  (n=3  or  4
each).  The  outer  nuclear  layer  of  the
heterozygotes (B, E) was thinner and the
photoreceptor  outer  segments  were
shorter than in wild-type mice (A, D).
The alterations were even greater in the
homozygotes (C, F). Differences were
more marked at 35 weeks of age than at
7 weeks of age. GCL, IPL, INL, OPL,
ONL, IS, OS, and RPE correspond to
ganglion  cell  layer,  inner  plexiform
layer,  inner  nuclear  layer,  outer
plexiform  layer,  outer  nuclear  layer,
inner  segment,  outer  segment,  and
retinal  pigment  epithelium.  The  scale
bar represents 50 µm.
Figure 5. Inner nuclear layer (INL) and
outer nuclear layer (ONL) thickness and
outer segment (OS) length in the central
retina.  A:  INL  thickness  did  not
significantly  differ  among  the
genotypes  at  the  any  age  examined.
ONL thickness (B) and OS length (C)
significantly  differed  among  the
genotypes  at  every  age  examined  (*
indicates  p<0.05,  Tukey–Kramer
multiple-comparisons test). At 35 weeks
of age, OS length in the homozygotes
was too short to be measured by our
method. We examined a single eye of
three or four animals of each genotype
at  each  age.  Data  shown  are  means
±standard error.
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383(20 mM Tris [pH.7.6], 1.14 M NaCl, 0.1% Tween-20), and
immunoreaction with Rho antibody was allowed to proceed
under  the  same  conditions  as  with  the  Rom1  and  Prph2
antibodies in high-salt TBST. The band between 25 kDa and
37 kDa was measured as the rhodopsin signal. The protein
level in each sample was standardized to the level of β-actin,
which  was  detected  with  a  human  β-actin  monoclonal
antibody conjugated to HRP (Product No. ab20272; Cosmo
Bio Co., Ltd., Tokyo, Japan).
Statistical analysis: The results were statistically analyzed by
a one-way analysis of variance (ANOVA) and expressed as
means±standard error when comparing groups. All multiple
pairwise comparisons were analyzed by the Tukey–Kramer
multiple comparisons test. A p value <0.05 was considered
statistically significant.
RESULTS
Discovery of a dominant mutant in Rom1 generated by N-
ethyl-N-nitrosourea  mutagenesis:  During  large-scale
screening of ENU-mutagenized mice, we used a funduscopic
camera to screen 2,515 first generation (G1) male mice for
dominant  abnormal  eye  phenotypes.  Identified
phenodeviants,  i.e.,  animals  that  exhibited  abnormal
phenotypes, were subsequently backcrossed to DBA/2J or
C3H/HeJ mice for inheritance testing. The inheritance tests
confirmed that some independent phenotypes were clearly
transmitted  to  the  next  generation.  A  catalog  of  the
independent phenotypes will be described by us in near future.
Comparison of the appearance of the fundi of heterozygous
M-1156 mice with the wild-type mice showed that they were
abnormal, and a mottled retina and narrowed arteries were
observed  in  the  abnormal  fundi  (Figure  1).  The  mutation
exhibited  a  dominant  inheritance  pattern.  No  other
abnormalities were observed in the M-1156 mice.
We mapped the mutant locus to the proximal region of
chromosome 19 by linkage analysis of backcrossed progeny
(Figure  2A).  The  mutated  locus  was  mapped  between
rs3023477 and D19Mit69, close to D19Mit42 (Figure 2B).
Although  according  to  the  public  genome  database
(ensembl) there are more than 400 genes within the critical
region, according to the PosMed web system Rom1, Stx3, and
Best1, which encode rod outer segment membrane protein 1,
Figure  6.  Electron  micrographs  of
retinas  from  35-week-old  Rom1+/+,
Rom1Rgsc1156/+, and Rom1Rgsc1156/Rgsc1156
mice (n=3 each). The bar represents 10
µm in A, B, and C and 1 µm in D, E, and
F.  The  photoreceptor  outer  segments
were shorter in the heterozygotes (B)
than  in  the  wild-type  mice  (A).
Remnants  of  the  photoreceptor  outer
segments were observed in 35-week-old
homozygotes  (C,  arrow).  At  high
magnification the diameters of the discs
clearly varied in the heterozygotes (E),
and the discs of the heterozygotes were
more  compactly  stacked  than  in  the
wild-type (D). (D-F) are high-magnified
views  of  outer  segment  in  (A-C),
respectively.
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384syntaxin  3,  and  bestrophin  1,  respectively,  were  strong
candidate genes for retinal degeneration. We used genomic
DNA from the mutant line to sequence their complete coding
and flanking intron regions to determine whether the mutant
phenotype was caused by a genetic alteration in Rom1, Stx3, or
Best1. To exclude the possibility that base changes were pre-
existing polymorphisms, we compared the sequences of the
mutant mice with those of the wild-type (DBA/2J and C57BL/
6J) mice. In addition, to exclude the possibility that base
changes in Prph2 contributed to the phenotype, we compared
the sequences of the mutant mice with those of the wild-type
(DBA/2J and C57BL/6J) mice. A single-base substitution,
T→C, at position 1,195 of Rom1 (M96760, National Center
for Biotechnology Information [NCBI]) was identified in the
M-1156 mutant line (Figure 3), and the base change caused
Trp to Arg amino acid substitution at position 182 of the
translated protein. The base substitution was found in exon 1
of Rom1, and the amino acid substitution was located in the
large intradiscal loop of Rom1. We designated the new Rom1
mutant allele Rom1Rgsc1156 (MGI accession number 3814074).
No other alterations or polymorphisms in the Rom1 coding
region were found when mutant mice and wild-type mice were
compared, nor were any sequence changes in Stx3, Best1, or
Prph2 detected in the mutant mice in a comparison with wild-
type mice.
Characterization of the phenotype of the Rom1Rgsc1156 mutant:
Careful examination of photomicrographs of the retinas of
Rom1Rgsc1156  heterozygotes  and  Rom1Rgsc1156  homozygotes
(n=3 or 4 each; Figure 4) revealed that the outer nuclear layer
was thinner and the outer segments of the photoreceptors were
shorter  in  the  heterozygotes  than  in  wild-type  mice.  The
alterations  were  more  marked  in  homozygotes  than  in
heterozygotes, and they progressed from 7 weeks of age to 35
weeks of age. There were only one or two rows of nuclei in
the outer nuclear layer of 35-week-old homozygotes, and the
inner and outer segments were almost entirely absent. There
were no significant differences among the genotypes in the
thickness of the inner nuclear layer at any age examined, but
there were significant differences in the thickness of the outer
nuclear layer and the length of the outer segments of the
photoreceptors (Figure 5).
Transmission electron microscopy was used to examine
the ultrastructure of photoreceptor outer segments (n=3 each;
Figure  8.  Photopic  electroretinograms  of  7-week-old  Rom1+/+,
Rom1Rgsc1156/+, and Rom1Rgsc1156/Rgsc1156 mice (n=4 each). There were
no significant differences in amplitude of the b-wave among the
genotypes. Data shown are means±standard error.
Figure  7.  Single-flash  electroret-
inograms  of  Rom1+/+,  Rom1Rgsc1156/+,
and  Rom1Rgsc1156/Rgsc1156  mice.  A:  The
amplitude  of  the  a-wave  differed
significantly  among  the  genotypes  at
every age examined (* indicates p<0.05,
Tukey–Kramer  multiple-comparisons
test). The reduction was most severe in
the homozygotes. B: The amplitude of
the  b-wave  also  differed  significantly
among  the  genotypes  (*  indicates
p<0.05,  Tukey–Kramer  multiple-
comparisons test), although there were
no significant differences between the
wild type and heterozygotes at 7 and 35
weeks. The number of eyes analyzed in
each  group  is  indicated  next  to  the
symbols.  Data  shown  are  means
±standard error.
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385Figure 6). The outer segments of the photoreceptors were
shorter in the heterozygotes than in the wild-type mice. Only
remnants of the outer segments of the photoreceptors were
observed  in  the  homozygotes  at  35  weeks  of  age.  High
magnification  revealed  that  the  outer  segments  of  the
photoreceptors of the heterozygotes were clearly disorganized
(the disc diameters varied and the discs were more compactly
arranged than in wild-type mice).
Finally, we performed electroretinography to evaluate
retinal  function.  Single-flash  ERGs  showed  that  the
amplitudes  of  the  a-wave  in  the  mutant  mice  were
significantly lower than in wild-type mice (Figure 7). The
degree of reduction was more severe in the homozygotes than
in the heterozygotes and was greater in 35-week-old mice than
in 7-week-old mice. In contrast, there were no significant
differences among the genotypes in the amplitude of the b-
wave of the photopic electroretinograms (Figure 8).
Expression of Rom1 and Prph2 in the Rom1Rgsc1156 mutant: To
examine whether the T→C single-base substitution in exon1
induces splice site changes, we sequenced retinal cDNA from
both  wild-type  mice  and  Rom1Rgsc1156  homozygotes.  The
mutant allele was expressed, and there were no splice site
changes in Rom1Rgsc1156 mutants (data not shown).
We also quantified the expression levels of both Rom1
and Prph2 in wild-type mice and Rom1Rgsc1156 mutants by
performing real-time PCR on samples from 8-week-old mice.
Normalization of expression of Rom1 to expression of Gapdh
revealed that an expression level in Rom1Rgsc1156 heterozygotes
was 68.6±8.7% (mean±standard error) of the level in the wild
type,  whereas  the  expression  level  in  homozygotes  was
40.4±3.9% of the wild-type level (Figure 9A). Expression of
Prph2 relative to Gapdh in heterozygotes and homozygotes
was 66.9±6.9% and 41.0±3.3%, respectively, of the level in
the  wild  type.  Rom1  and  Prph2  mRNA  levels  relative  to
Gapdh mRNA differed significantly among the genotypes.
When  expression  of  Rom1  was  normalized  to  Rho,  the
expression level in Rom1Rgsc1156 heterozygotes was 80.5±7.0%
of the wild-type level, whereas in homozygotes the expression
level was 93.5±6.2% of the wild-type level (Figure 9B). The
relative expression of Prph2 to Rho in heterozygotes and
homozygotes was 78.1±5.0% and 94.6±4.6%, respectively, of
expression  in  the  wild  type.  No  significant  differences  in
Rom1 or Prph2 mRNA levels relative to Rho mRNA were
detected among the genotypes.
Production of Rom1 and Prph2 in the Rom1Rgsc1156 mutant: To
investigate the production of Rom1 and Prph2 in Rom1Rgsc1156
mutants, we performed immunohistochemistry and western
blotting on samples obtained from mice at 3 weeks of age
when there was still little change in the thickness of the outer
nuclear layer and the length of the inner and outer segments
of the photoreceptors at the light microscopic level. Rom1
immunoreactivity in the retina was decreased in heterozygotes
compared  to  wild-type  mice  (Figure  10B),  and  Rom1
immunoreactivity was markedly reduced in the homozygotes
(Figure 10C). Prph2 immunoreactivity was similarly reduced
in both the heterozygotes and homozygotes (Figure 10F,G).
Western  blot  analysis  showed  a  decreased  density  of
Rom1 and Prph2 from the Rom1Rgsc1156 mutants (Figure 11A),
and the density of Rho from the Rom1Rgsc1156 mutants was also
decreased  (Figure  11B).  Semiquantitative  analysis  by
densitometry  showed  that  Rom1  immunoreactivity  in
Rom1Rgsc1156 heterozygotes and homozygotes was 51.6±8.2%
and 2.8±0.3%, respectively, of that in wild-type mice (Figure
11C).  The  immunoreactivity  of  Prph2  from  Rom1Rgsc1156
heterozygotes  and  homozygotes  was  59.3±12.4%  and
17.4±3.6%, respectively, of the immunoreactivity of Prph2
from wild-type mice. The immunoreactivity of Rho from the
Rom1Rgsc1156 heterozygotes and homozygotes was 70.4±6.3%
Figure 9. Expression levels of Rom1 and
Prph2 in mouse retinas from 8-week-
old  Rom1+/+,  Rom1Rgsc1156/+,  and
Rom1Rgsc1156/Rgsc1156 mice (n=3 each). A:
Rom1  and  Prph2  mRNA  levels  are
expressed relative to glyceraldehyde-3-
phosphate  dehydrogenase  (Gapdh)
mRNA  level.  The  relative  Rom1  and
Prph2  mRNA  levels  differed
significantly  among  the  genotypes  (*
indicates  p<0.05,  Tukey–Kramer
multiple-comparisons  test).  B:  Rom1
and Prph2 mRNA levels are expressed
relative to the rhodopsin (Rho) mRNA
level.  No  significant  differences  in
relative Rom1 or Prph2 mRNA levels
were  observed  among  the  genotypes.
Data shown are means±standard error.
The data were normalized to wild-type
values, which were set equal to 100%.
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386and 25.9±4.7%, respectively, of the immunoreactivity of the
Rho from wild-type mice. The level of each protein differed
significantly among the genotypes.
DISCUSSION
Retinal  degeneration  in  Rom1Rgsc1156  mutants:  Rom1Rgsc1156
mutants have a T→C single base substitution at position 1,195
of  Rom1  (M96760,  NCBI)  and  no  mutations  in  Prph2.
Sequence  analysis  of  retinal  cDNA  around  the  mutation
showed that the mutant allele was expressed and that the
mutation did not alter the splice site. The results of the real-
time PCR suggested that the decrease in Rom1 and Prph2
expression relative to Gapdh expression was attributable to
the decrease in thickness of the outer nuclear layer because
there were no significant differences in Rom1 or Prph2 mRNA
levels  among  the  genotypes  after  normalization  to  Rho
mRNA. In short, since the total expression levels of Rom1,
Prph2, and Rho in the mutant appear to be associated with the
thickness of the outer nuclear layer, a protein with an Arg
substituted for Trp at position 182 of the normal Rom1 protein
should be produced.
Immunohistochemistry at 3 weeks of age showed that the
immunoreactivity of Prph2 as well as Rom1 was reduced in
Rom1Rgsc1156 mutants, and western blot analysis demonstrated
that the Rom1 and Prph2 levels in Rom1Rgsc1156 mutants were
significantly decreased. Interestingly, the Rho level was also
decreased in Rom1Rgsc1156 mutants at 3 weeks of age. A study
of  knockout  and  transgenic  mice  showed  that  retinal
degeneration occurs when the combined level of both Rom1
and Prph2 is only about 60% of their combined level in wild-
type mice [32]. Our semiquantitative analysis of western blots
demonstrated that the combined level of both Rom1 and Prph2
was already below that percentage in Rom1Rgsc1156 mutants at
3 weeks of age, suggesting that photoreceptor degeneration in
Rom1Rgsc1156 mutants occurred at least by 3 weeks of age. Why
was  Prph2  decreased  in  Rom1Rgsc1156  mutants?  Prph2  and
Rom1 interact noncovalently via their large intradiscal loops
to  produce  homotetrameric  and  heterotetrameric  core
complexes [33-35]. Since the Trp182 of Rom1 is localized in
the intradiscal loop, it may induce unstable heterotetramers
and homotetramers in Rom1Rgsc1156 mutants. There is little
Rom1 or Prph2 immunoreactivity in the inner segment of
Rom1Rgsc1156 mutants, and immunoreactivity for both proteins
is decreased in the outer segment in a genotype-dependent
manner, suggesting that mutant Rom1–Prph2 heterotetramers
and mutant Rom1 homotetramers are degraded immediately
Figure 10. Immunohistochemical localization of retinal outer segment membrane protein 1 (Rom1) and peripherin/rds (Prph2) in the retinas
of 3-week-old Rom1+/+, Rom1Rgsc1156/+, and Rom1Rgsc1156/Rgsc1156 mice. Rom1 immunoreactivity was decreased in the outer segments of the
heterozygotes (B) in comparison with wild-type mice (A), and Rom1 immunoreactivity was markedly reduced in the homozygotes (C). Prph2
immunoreactivity in the outer segment was also decreased (E, F, G). No signals were detected in the retinas of wild-type mice when peptide
absorption tests were performed (D, H). The bar represents 50 µm. GCL, IPL, INL, OPL, ONL, IS, OS, and RPE refer to ganglion cell layer,
inner plexiform layer, inner nuclear layer, outer plexiform layer, outer nuclear layer, inner segment, outer segment, and retinal pigment
epithelium.
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387after subunit assembly. Unfortunately, because of the small
amount  of  mutant  Rom1  in  the  homozygotes,  our
immunoprecipitation  analysis  failed  to  show  that  mutant
Rom1 binds Prph2. In vitro biochemical analyses of subunit
assembly  may  elucidate  which  core  complexes  are
components in Rom1Rgsc1156 mutants.
The  ERGs  showed  significant  differences  among  the
genotypes in the amplitude of the a-wave in single-flash ERGs
but not in the amplitude of the b-wave in photopic ERGs.
These findings suggested that there was little effect on the
function of cone photoreceptors in Rom1Rgsc1156 mutants at 7
weeks of age but that there was significant deterioration of the
function of rod photoreceptors in Rom1Rgsc1156 mutants. Rod
photoreceptor degeneration should mainly have occurred in
Rom1Rgsc1156 mutants because Rom1 is produced exclusively
in rod photoreceptors.
All of the above findings taken together suggest that
Trp182Arg mutant Rom1 decreases the levels of wild-type
Prph2 and Rom1, which in turn results in a reduced level of
Prph2-containing  tetramers  in  the  disc  rim  region  and
ultimately results in unstable disorganized outer segments and
photoreceptor degeneration [34,36-38].
Phenotypic  severity  in  Rom1Rgsc1156  mutants:  Light
microscopy showed that the thickness of the outer nuclear
layer in 7-week-old Rom1Rgsc1156/+ mice was almost the same
as in 2-month-old rds/+ mice [39]; however, the electron
microscopic appearance of the outer segments was extremely
different. The disc diameters of the Rom1Rgsc1156/+ mice varied
and  their  discs  were  compactly  stacked,  while  the  outer
segments of the rds/+ mice were whorls [7,40]. The length of
the outer segments in the rds/+ mice was much shorter than
in the in Rom1Rgsc1156/+ mice and their length in Rom1+/− mice
was  almost  the  same  as  their  length  in  wild-type  mice.
According to the previous results [32], the levels of Prph2 and
Rom1  in  Rom1+/−  mice  were  106±4%  and  58±2%,
respectively, of their level in the wild type, whereas their
levels in rds/+ mice were 26±2% and 67±2%, respectively. In
Rom1Rgsc1156/+  mice,  the  levels  of  Prph2  and  Rom1  were
59.3±12.4% and 51.6±8.2%, respectively. Taken together,
these results suggest that the phenotypic severity in outer
segments is due to the amount of Prph2-containing tetramers,
which are required for higher order disulfide-linked oligomer
formation because the level of oligomers is important for
stable photoreceptor disc formation [36,37].
Rom1Rgsc1156 mutants can serve as a new animal model of
human retinitis pigmentosa: Sequence alterations in human
ROM1  associated  with  RP  have  been  reported.  The  three
ROM1 mutations (p.Gly80fs, p.Leu114fs, p.Gly113Glu) are
manifested by digenic RP in combination with a Leu185Pro
mutation in PRPH2, and only one of these mutations has an
essentially  normal  phenotype  [15,16].  The  p.Gly80fs  and
p.Leu114fs mutations result in frameshifts early in the coding
region  and  a  downstream  premature  stop  at  codon  131,
suggesting that these mutations do not encode a functional
protein  and  therefore  are  null  alleles.  Production  of  the
p.Gly113Glu Rom1 protein is 20-fold lower than production
Figure  11.  Western  blot  analysis  of
retinal outer segment membrane protein
1  (Rom1),  Prph2,  and  Rho  in  retinas
from  3-week-old  Rom1+/+,
Rom1Rgsc1156/+, and Rom1Rgsc1156/Rgsc1156
mice (n=6 each). A: Western blots of 10
µg of retinal protein with antibodies to
Rom1, Prph2, and β-actin. The stripped
membrane  was  reprobed  with
antibodies  to  Prph2  and  β-actin.  B:
Western blots of 0.1 µg of retinal protein
with antibodies to Rho and β-actin. The
stripped membrane was reprobed with
β-actin antibodies. C: Semiquantitative
analysis  of  Rom1,  Prph2,  and  Rho
levels. The western blot band intensities
were measured with ImageJ software.
Rom1, Prph2, and Rho protein levels
were normalized to β-actin levels. The
intensity  (mean±standard  error)  was
normalized to wild-type values, which
were set equal to 100%. Protein levels
differed  significantly  among  the
genotypes (* indicates p<0.05, Tukey–
Kramer multiple-comparisons test).
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388of wild-type Rom1 when expressed in COS-1 cells, indicating
that a mutation resulting in p.Gly113Glu behaves as a null
allele [37]. Biochemical studies have demonstrated that the
p.Leu185Pro Prph2 mutant assembles with wild-type Prph2
and Rom1 to form core tetramers, but unlike wild-type Prph2
is unable to self-assemble into the core homotetramers that are
required for higher order disulfide-linked oligomer formation
[34,37].  Based  on  these  findings,  it  seems  likely  that  the
pathogenesis of digenic RP is attributable to a large decrease
in  the  amount  of  core  complexes,  such  as  Prph2
homotetramers and Prph2-Rom1 heterotetramers.
Two  amino  acid  substitutions  (p.Pro60Thr  and
p.Thr108Met) in a single allele of ROM1 in an autosomal
dominant RP patient and three different single amino acid
substitutions  (p.Gly75Asp,  p.Leu114fs,  p.Arg242Glu)  in
patients with sporadic RP have been reported [41-43]. None
of these substitutions has been concluded to be pathogenic
because  the  pedigrees  reported  have  been  so  small  that
statistically significant co-segregation analyses are limited.
Loss  of  one  allele  of  Rom1  in  mice  does  not  induce
photoreceptor  degeneration,  implying  that  p.Leu114fs  is
unlikely to be pathogenic in humans [5].
In  conclusion,  the  evidence  is  convincing  that  the
Trp182Arg substitution in Rom1Rgsc1156 mutants causes retinal
degeneration,  suggesting  that  mutations  in  the  large
intradiscal  loop  of  Rom1  may  affect  the  formation  of
homotetrameric  and  heterotetrameric  core  complexes  and
their stability. The Rom1Rgsc1156 mutant will not only provide
additional information about subunit assembly but will also
serve as a new animal model of human autosomal dominant
RP. The prevalence of nondigenic dominant ROM1 mutations
is less than 1% [43,44], but Rom1 may play a more important
role in stabilizing the core complex than previously expected.
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